Iovance Biotherapeutics Inc (IOVA)
NASDAQ:IOVA
Holding IOVA?
Track your performance easily

Iovance Biotherapeutics (IOVA) Financial Statements

2,863 Followers

Iovance Biotherapeutics Financial Overview

Iovance Biotherapeutics's market cap is currently ―. The company's EPS TTM is $-1.682; its P/E ratio is -6.19; Iovance Biotherapeutics is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is $-0.30. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 31.11M$ 715.00K$ 482.00K$ 469.00K$ 238.00K
Gross Profit$ -262.00K$ -6.55M$ -3.88M$ -3.87M$ 238.00K
EBIT$ -98.60M$ -114.38M-$ -115.00M$ -104.95M
EBITDA$ -85.37M$ -106.82M--$ -97.02M
Net Income Common Stockholders$ -97.06M$ -113.00M$ -116.38M$ -113.80M$ -106.53M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 412.54M$ 356.19M$ 279.87M$ 361.37M$ 250.89M
Total Assets$ 964.32M$ 869.83M$ 780.35M$ 852.32M$ 757.29M
Total Debt$ 81.68M$ 84.37M$ 75.86M$ 79.48M$ 80.71M
Net Debt$ -330.86M$ -271.83M$ -204.00M$ -281.90M$ -170.18M
Total Liabilities$ 195.78M$ 189.81M$ 195.74M$ 178.31M$ 178.72M
Stockholders Equity$ 768.54M$ 680.02M$ 584.61M$ 674.01M$ 578.57M
Cash Flow-
Free Cash Flow$ -98.84M$ -126.47M--$ -103.47M
Operating Cash Flow$ -98.40M$ -122.30M$ -83.90M$ -84.10M$ -93.95M
Investing Cash Flow$ 40.22M$ -111.51M$ -72.84M$ -79.01M$ -156.78M
Financing Cash Flow$ 152.82M$ 193.58M$ 962.00K$ 202.80M$ 1.02M
Currency in USD

Iovance Biotherapeutics Earnings and Revenue History

Iovance Biotherapeutics Debt to Assets

Iovance Biotherapeutics Cash Flow

Iovance Biotherapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis